Short-term effects of two drugs containing testosterone on neuro-physiological functio

Phase 1

• Conditions: HYPOGONADISM; MedDRA version: 16.1Level: PTClassification code 10058359Term: HypogonadismSystem Organ Class: 10014698 - Endocrine disorders; Therapeutic area: Health Care [N] - Population Characteristics [N01]

• Registration Number: EUCTR2013-001734-17-IT
• Lead Sponsor: niversity of Rome Foro Italico

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-10-22
• Last Update Posted: 26 February 2018

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

HYPOGONADISM; HEALTHY VOLUNTEERS
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 45
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 15

Exclusion Criteria

ALL DISEASES EXCEPT HYPOGONADISM; USE OF DRUGS

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified